Publication | Closed Access

Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages

InflammationActive Anti-allergic DrugCytokineAnti-inflammatoryAllergyAutoimmune DiseaseLung InflammationMedicinePro-inflammatory Cyclooxygenase-2ImmunologyAutoimmunityInnate ImmunityImmunosuppressionPhagocyteImmunotherapyPharmacologyRaw264.7 MacrophagesOxidative Stress